Clinical utility and quality of newly introduced contrast-enhanced ultrasound (CEUS) at a tertiary center for gastroenterology & hepatology – results from a single-center registry
Zeitschrift für Gastroenterologie · 01.05.2025 · 63 (05) · e321
DOI: 10.1055/s-0045-1809201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.05.2025. Verfasst von D Venturi und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Contrast-enhanced ultrasound (CEUS) has become an essential diagnostic tool, particularly for characterizing hepatic lesions, but requires high quality examinations. Material and Methods This retrospective analysis of a single-center registry aimed to evaluate referral indications, epidemiological and clinical information, assess diagnostic accuracy, and analyze study and documentation quality. Diagnostic accuracy was validated by reference standards (histology, MRI, CT).
Results
Among 189 CEUS examinations, population 57.1% male, mean age 63.8 (±15.9) years, 159 (84.1%) targeted hepatic lesions. Non-hepatic examinations (15.9%) included pancreas lesions/cysts (n=13), gallbladder lesions (n=5), bile ducts (n=4), and other regions (n=8). Lesion sizes ranged from 0.5cm to 12.7cm (mean 3.52cm). Hepatic indications primarily included suspected hepatocellular carcinoma (16.4%), hemangioma (14.3%), metastasis (13.2%), and focal nodular hyperplasia (9.5%). Reference standards used included histology (50%), MRI (20.1%), and CT (17.9%). Diagnostic accuracy in differentiating benign from malignant liver lesions (n=125 evaluable cases) was 87.9%. Concerning lesion prediction, the final diagnosis was correctly included in the differential diagnoses in 81.4%. Interestingly, correct classification of benign/malignant liver lesions decreased from 93.6% in 2021-2022 to 81.9% in 2023-2024. Concerning all studies, documentation quality demonstrated consistently reported lesion localization (100%), frequent B-mode (93.1%) and CEUS image descriptions (92.1%), yet incomplete lesion size documentation (67.7%). Explicit benign versus malignant classification was provided in 73.3% of reports, with differential diagnoses listed in 27.2% of cases. A LI-RADS classification among potential HCC-lesions was provided in 46.1%, decreasing also from 63.6% in 2021-2022 to 23.5% in 2023-2024, highlighting room for improvement.
Conclusion
Diagnostic accuracy was high despite CEUS having been only recently introduced at this department. However, accurate description of findings and adequate documentation of results are of utmost importance to ensure reliability and diagnostic value. Highlighting areas of improvement, this analysis underscores the essential role for ongoing quality assurance to maintain high quality examinations. Publication History Article published online: 13 May 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Venturi, D., Koutny, F., Gabriel, L., Maieron, A., & Prosenz, J. (2025). Clinical utility and quality of newly introduced contrast-enhanced ultrasound (CEUS) at a tertiary center for gastroenterology & hepatology – results from a single-center registry. Zeitschrift für Gastroenterologie, 63(05), e321. https://doi.org/10.1055/s-0045-1809201
Vancouver
Venturi D, Koutny F, Gabriel L, Maieron A, Prosenz J. Clinical utility and quality of newly introduced contrast-enhanced ultrasound (CEUS) at a tertiary center for gastroenterology & hepatology – results from a single-center registry. Zeitschrift für Gastroenterologie. 2025;63(05):e321. doi:10.1055/s-0045-1809201
BibTeX
@article{Venturi2025,
author = {Venturi, D and Koutny, F and Gabriel, L and Maieron, A and Prosenz, J},
title = {Clinical utility and quality of newly introduced contrast-enhanced ultrasound (CEUS) at a tertiary center for gastroenterology & hepatology – results from a single-center registry},
journal = {Zeitschrift für Gastroenterologie},
year = {2025},
volume = {63},
number = {05},
pages = {e321},
doi = {10.1055/s-0045-1809201}
}
EUVIMED